Soleno Therapeutics Inc
SLNODelisted May 18, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001484565
Soleno Therapeutics Inc was delisted on May 18, 2026; its insiders filed their last Form 4 on May 18, 2026; 227 institutions reported holding it in 13F filings for Q1 2026, worth $2.09B in total; no superinvestor held it.
Q1 2023 vs. Q4 2022
How the institutions holding Soleno Therapeutics Inc changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Of which not filed for Q1 2023 | Q1 2023 | Change |
|---|---|---|---|---|
| Holders | 26 | 1 | 21 | −4 |
| Shares | 3.03M | 1.20M | 3.32M | +1.49M (+81.3%) |
| Value | $6.00M | $2.38M | $7.06M | +$3.44M (+94.9%) |
1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (3)
Institutions that held Soleno Therapeutics Inc at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Carlyle Group Inc. | 1,201,506 | $2.54M | 0.08% |
| Dimensional Fund Advisors LP | 30,139 | $64.5K | 0.00% |
| Northwestern Mutual Wealth Management Co | 1 | $2 | 0.00% |
Sold out (7)
Institutions that held Soleno Therapeutics Inc at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Millennium Management LLC | 45,876 | $91.0K |
| Two Sigma Securities, LLC | 19,932 | $39.5K |
| Ergoteles LLC | 12,570 | $24.9K |
| Susquehanna International Group, LLP | 11,545 | $22.9K |
| Citigroup Inc | 100 | $198 |
| Morgan Stanley | 14 | $28 |
| Royal Bank of Canada | 6 | $0 |
Not filed for Q1 2023 yet (1)
Institutions that held Soleno Therapeutics Inc at the end of Q4 2022 and haven't filed a 13F for Q1 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Abingworth LLP | 1,201,506 | $2.38M |